查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2023900

寵物益生菌市場預測至2034年－全球產品類型、劑型、寵物類型、功能、成分、標籤、最終用戶、通路和區域分析

Pet Probiotics Market Forecasts to 2034 - Global Analysis By Product Type, Form, Pet Type, Functionality, Ingredient, Claim, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球寵物益生菌市場規模將達到 11 億美元，並在預測期內以 8.9% 的複合年成長率成長，到 2034 年將達到 23 億美元。

寵物益生菌是指添加到營養補充劑、零食和食品添加劑中的活性有益微生物，旨在支持伴侶動物的消化器官系統和免疫健康。這些產品透過平衡腸道菌叢、增強營養吸收和抑制有害細菌的生長來發揮作用，適用於多種寵物。隨著寵物「擬人化」程度的提高、預防保健意識的增強以及消費者越來越傾向於選擇天然、科學驗證的寵物健康解決方案而非藥物治療常見的胃腸道和免疫相關疾病，寵物益生菌市場正經歷強勁成長。

寵物日益“擬人化”，以及寵物健康方面的支出不斷增加。

寵物飼主越來越將心愛的寵物視為家庭成員，這促使他們在高品質的健康產品上投入更多資金，包括旨在支持消化器官系統和免疫系統的益生菌。這種觀念的轉變正在改變寵物護理，使其從簡單的餵食和提供適當的生活環境，轉變為堪比人類醫療保健的全面健康管理。飼主積極尋求補充劑來解決腹瀉、便秘和過敏等特定症狀，並將益生菌視為一種安全且天然的預防措施。獸醫的推薦進一步推動了需求，專家也意識到腸道健康在動物整體健康中扮演的重要角色。消費者越來越願意為經臨床驗證的配方支付更高的價格，這為已開發市場的持續成長創造了動力。

法律規範不力，品質參差不齊。

寵物益生菌產品缺乏標準化監管是消費者信心的一大障礙，並導致市場區隔。與藥品不同，動物益生菌在許多地區上市前核准要求較少，導致活性成分濃度、菌株活力和保存期限穩定性有顯著差異。市面上有些產品的活菌數低於標示值，或不含經科學檢驗的菌株，導致功效不穩定，令消費者失望。這種監管缺陷使得寵物飼主難以區分優質產品和無效替代品，可能會阻礙那些謹慎的消費者購買昂貴的補充劑，因為他們希望找到功效可靠的產品。

擴大菌株特異性治療應用的研究

一系列關於微生物群對腸腦軸和整體健康影響的科學發現，正為寵物益生菌開闢新的治療途徑，使其不再局限於支持消化功能。研究正在鑑定出一些特定的細菌菌株，它們能夠緩解焦慮、減輕發炎、控制慢性腎臟病並改善伴侶動物的口腔衛生。獸用益生菌生產商可以利用這些發現，透過開發具有確切療效的疾病特異性配方，在競爭激烈的市場中脫穎而出。隨著菌株特異性益處的臨床證據不斷積累，與獸醫醫院、寵物保險公司和尋求科學檢驗的複雜寵物健康解決方案的專業零售商的合作機會也在增加。

與改善腸道健康的其他解決方案競爭

後生元、益生元和發酵全食物補充劑等新型替代品的出現，可能會改變消費者對傳統益生菌產品的興趣。後生元含有有益代謝物，但不含活菌，因此保存期限更長，解決了運輸和儲存過程中益生菌存活率低的問題。益生元纖維能夠選擇性地利用腸道菌群作為營養物質，與消化支持補充劑相比，它是一種更簡單且通常成本更低的選擇。此外，生鮮和發酵寵物食品天然含有豐富的微生物群，這可能會降低對益生菌補充劑的相對需求。這些相互競爭的方法可能會導致市場細分，迫使益生菌生產商不斷創新，否則將面臨市場佔有率被更簡單、更穩定的替代品蠶食的風險。

新冠疫情的影響

疫情顯著加速了寵物益生菌的普及，封鎖措施加深了人與動物之間的聯繫，並將醫療保健支出轉向預防性保健。由於獸醫服務減少，飼主開始使用市售的營養補充品在家處理寵物的一些小毛病。起初，供應鏈中斷影響了原料的供應，但隨著飼主在隔離期間將寵物的健康放在首位，寵物營養補充品市場展現了韌性。遠距辦公的興起使飼主更容易每天給寵物服用益生菌，從而養成了一種永續的習慣。疫情後寵物飼養量的激增，加上混合辦公模式的普及，導致所有益生菌產品類型的需求持續高漲。

在預測期內，狗類產品預計將佔據最大的市場佔有率。

在預測期內，犬類市場預計將佔據最大的市場佔有率。這反映了犬類是全球主要的伴侶動物，且容易罹患消化器官系統疾病。與其他寵物相比，犬隻更容易出現飲食不規律、壓力性腹瀉和抗生素相關性胃腸道疾病，這為益生菌干預提供了更多機會。犬類專用益生菌產品種類繁多，包括咀嚼片、粉劑和膠囊，並根據犬種、體型和健康狀況進行配製，其產品範圍遠遠超過其他任何寵物類別。獸醫強烈建議使用犬類益生菌，臨床研究也表明，益生菌菌株在犬類中的有效性比在貓或其他伴侶動物中更為廣泛。

在預測期內，「整體健康」細分市場預計將呈現最高的複合年成長率。

在預測期內，「綜合健康」細分市場預計將呈現最高的成長率。這主要歸因於寵物飼主日益成長的趨勢，即不再將益生菌視為特定症狀的治療手段，而是將其作為日常保健補充劑。這種消費模式將益生菌定位為日常預防保健的重要組成部分，而非應對現有健康問題的被動方案，與疫苗接種和寄生蟲防治並駕齊驅。製造商們正積極響應這一趨勢，推出包含多種菌株的多種配方，以同時支持消化、免疫、皮膚健康和活力。對於忙碌的飼主而言，每天只需服用一種產品即可輕鬆補充營養，這無疑更具吸引力，也更符合他們簡化寵物健康管理的需求。強調系統性功效的行銷策略順應了「像對待人類一樣對待寵物」的趨勢，因此比專注於特定症狀的功能性產品類別更能推動市場接受度。

市佔率最大的地區

在預測期內，北美地區預計將保持最大的市場佔有率。這主要得益於該地區較高的寵物擁有率、先進的獸醫基礎設施以及消費者對高階寵物保健產品的強勁需求。該地區完善的零售通路，包括寵物專賣店和電商平台，為益生菌產品的廣泛供應提供了保障。諸如美國國家動物營養補充品委員會 (NASC) 品質認證標誌等法規結構，透過自願合規標準增強了消費者的信心。北美寵物飼主對微生物組科學的高度認知以及與獸醫的頻繁諮詢，推動了益生菌產品的穩定需求。總部位於該地區的主要益生菌生產商受益於其成熟的分銷網路和品牌知名度，從而鞏固了其在北美市場的領先地位。

複合年成長率最高的地區

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於寵物擁有量的激增、中產階級可支配收入的成長以及人們對西式寵物護理方式的日益了解。在中國、日本和韓國等國家，寵物飼主與寵物之間的關係正在發生顯著變化，伴侶動物越來越被視為值得獲得高品質照顧的家庭成員。獸醫網路的擴張和電子商務的蓬勃發展使得益生菌即使在二、三線城市也更容易獲得。尤其在中國，以微生物組為基礎的治療方法作為傳統醫學的接受度正在不斷提高。國際寵物產品公司正積極拓展在全部區域的經銷夥伴，而本地製造商也在開發針對特定地區的配方；這些因素共同推動了亞太地區令人矚目的成長。

免費客製化服務

所有購買此報告的客戶均可享受以下免費自訂選項之一。

  • 企業概況
    • 對其他市場參與企業進行全面分析（最多 3 家公司）
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 我們根據客戶要求提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 透過產品系列、地理覆蓋範圍和策略聯盟對標主要企業。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 成長機會和重點投資領域
  • 工業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章 全球寵物益生菌市場：依產品類型分類

  • 食物來源的益生菌
    • 乾糧
    • 濕糧
    • 零食/功能性零食
  • 補充
    • 單菌株益生菌
    • 多菌株益生菌

第6章 全球寵物益生菌市場：以劑型分類

  • 粉末
  • 軟咀嚼片
  • 膠囊
  • 液體
  • 貼上

第7章 全球寵物益生菌市場：依寵物類型分類

  • 狗
  • 貓
  • 鳥
  • 小型哺乳動物
  • 爬蟲類和異寵

第8章：全球寵物益生菌市場：依功能分類

  • 消化系統健康
  • 免疫功能改善
  • 過敏與皮膚健康
  • 口腔和牙齒健康
  • 體重管理
  • 全面健康

第9章：全球寵物益生菌市場：依成分分類

  • 乳酸桿菌
  • 雙歧桿菌
  • 芽孢桿菌（土壤微生物）
  • 鏈球菌
  • 酵母來源的益生菌
  • 多菌株混合物

第10章：全球寵物益生菌市場：依標籤分類

  • 純天然
  • 非基因改造
  • 無穀物
  • 有機的
  • 不含過敏原
  • 不含人工添加物或防腐劑

第11章 全球寵物益生菌市場：依最終用戶分類

  • 個人寵物飼主
  • 獸醫學和臨床應用
  • 寵物繁殖者和動物收容所

第12章 全球寵物益生菌市場：依通路分類

  • 線上
    • 電子商務平台
    • 品牌網站
  • 離線
    • 動物診所
    • 寵物專賣店
    • 超級市場和大賣場
    • 藥局

第13章 全球寵物益生菌市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 其他
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲地區

第14章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第15章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第16章：公司簡介

  • ADM
  • Alltech, Inc.
  • Kerry Group PLC
  • International Flavors & Fragrances Inc.
  • dsm-firmenich
  • Cargill, Incorporated
  • Kemin Industries, Inc.
  • Probi AB
  • BENEO GmbH
  • Ingredion Incorporated
  • Novonesis Group
  • Lallemand Inc.
  • Chr. Hansen Holding A/S
  • Lesaffre Group
  • Evonik Industries AG
Product Code: SMRC35111

According to Stratistics MRC, the Global Pet Probiotics Market is accounted for $1.1 billion in 2026 and is expected to reach $2.3 billion by 2034 growing at a CAGR of 8.9% during the forecast period. Pet probiotics are live beneficial microorganisms formulated into supplements, treats, and food additives designed to support the digestive and immune health of companion animals. These products work by balancing the gut microbiome, enhancing nutrient absorption, and inhibiting harmful bacteria growth across various pet species. The market is experiencing robust expansion driven by increasing pet humanization, rising awareness of preventive healthcare, and growing consumer preference for natural, science-backed pet wellness solutions over pharmaceutical interventions for common gastrointestinal and immune-related conditions.

Market Dynamics:

Driver:

Rising pet humanization and expenditure on pet wellness

Pet owners increasingly treat their animals as family members, leading to higher spending on premium health products including probiotics for digestive and immune support. This emotional shift transforms pet care from basic feeding and shelter to comprehensive wellness management comparable to human healthcare standards. Owners actively seek out supplements that address specific conditions like diarrhea, constipation, and allergies, viewing probiotics as safe, natural preventatives. Veterinary recommendations further amplify demand as professionals recognize gut health's role in overall animal wellbeing. The willingness to pay premium prices for clinically validated formulations creates sustained market momentum across developed economies.

Restraint:

Limited regulatory oversight and quality inconsistency

The absence of standardized regulations for pet probiotic products creates significant consumer trust barriers and market fragmentation. Unlike pharmaceuticals, probiotics for animals face minimal pre-market approval requirements in many jurisdictions, resulting in wide variation in product potency, strain viability, and shelf-life stability. Some marketed products contain fewer live organisms than claimed or lack scientifically validated strains, leading to inconsistent outcomes and consumer disappointment. This regulatory gap makes it difficult for pet owners to distinguish high-quality formulations from ineffective alternatives, potentially slowing adoption rates among cautious buyers who demand proven efficacy before investing in premium-priced supplements.

Opportunity:

Expanding research into strain-specific therapeutic applications

Ongoing scientific discoveries about the gut-brain axis and microbiome's influence on systemic health open new therapeutic avenues for pet probiotics beyond basic digestion. Research is identifying specific bacterial strains that alleviate anxiety, reduce inflammation, manage chronic kidney disease, and improve oral hygiene in companion animals. Veterinary probiotic manufacturers can capitalize on these findings by developing condition-targeted formulations with documented efficacy, differentiating their products in a crowded marketplace. As clinical evidence accumulates for strain-specific benefits, opportunities grow for partnerships with veterinary clinics, pet insurance providers, and specialty retailers seeking scientifically validated solutions for complex pet health challenges.

Threat:

Competition from alternative gut health solutions

Emerging alternatives including postbiotics, prebiotics, and fermented whole-food supplements threaten to divert consumer interest away from traditional probiotic products. Postbiotics, which contain beneficial metabolites without live bacteria, offer longer shelf stability and eliminate concerns about viability during shipping and storage. Prebiotic fibers that selectively feed native gut bacteria provide simpler, often lower-cost options for digestive support. Additionally, raw and fermented pet food diets naturally contain diverse microbial populations, potentially reducing the perceived need for supplemental probiotics. These competing approaches may fragment the market, pressuring probiotic manufacturers to innovate or risk losing market share to simpler or more stable alternatives.

Covid-19 Impact:

The pandemic significantly accelerated pet probiotic adoption as lockdowns increased human-animal bonding and shifted healthcare spending toward preventive wellness. With veterinary clinics operating at reduced capacity, owners turned to over-the-counter supplements to manage minor pet health issues at home. Supply chain disruptions initially affected raw material availability, but the pet supplement category proved resilient as owners prioritized companion animal health during isolation periods. Remote work arrangements allowed owners to more easily administer daily probiotic regimens, establishing lasting habits. The post-pandemic pet population surge, combined with continued hybrid work patterns, maintains elevated demand levels across all probiotic product categories.

The Dogs segment is expected to be the largest during the forecast period

The Dogs segment is expected to account for the largest market share during the forecast period, reflecting the global dominance of canine companionship and dogs' susceptibility to digestive issues. Dogs experience higher rates of dietary indiscretion, stress-induced diarrhea, and antibiotic-associated gastrointestinal disturbances compared to other pets, creating frequent opportunities for probiotic intervention. The extensive range of dog-specific probiotic products, including chews, powders, and capsules formulated for breed sizes and conditions, far exceeds offerings for any other pet category. Veterinary recommendation patterns strongly favor canine probiotics, with clinical studies validating strain efficacy more extensively for dogs than for cats or other companion animals.

The Overall Wellness segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Overall Wellness segment is predicted to witness the highest growth rate, as pet owners increasingly adopt probiotics as daily maintenance supplements rather than condition-specific treatments. This consumption pattern positions probiotics as foundational elements of routine preventive care, alongside vaccinations and parasite control, rather than reactive solutions for existing health problems. Manufacturers are responding with broad-spectrum formulations containing multiple bacterial strains that support digestion, immunity, skin health, and vitality simultaneously. The convenience of single-product daily supplementation appeals to busy owners seeking simplified wellness routines. Marketing emphasizing whole-body benefits resonates with humanized pet care trends, driving faster adoption than condition-specific functional categories.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, advanced veterinary infrastructure, and strong consumer willingness to spend on premium pet wellness products. The region's sophisticated retail channels, including dedicated pet specialty stores and e-commerce platforms, provide extensive probiotic product availability. Regulatory frameworks like the NASC (National Animal Supplement Council) quality seal offer consumer confidence through voluntary compliance standards. High awareness of microbiome science among North American pet owners, coupled with frequent veterinary consultations, drives consistent demand. Major probiotic manufacturers headquartered in the region benefit from established distribution networks and brand recognition, reinforcing North American market leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapidly rising pet ownership, expanding middle-class disposable incomes, and increasing exposure to Western pet care practices. Countries including China, Japan, and South Korea are witnessing significant shifts in pet-owner relationships, with companion animals increasingly viewed as family members deserving premium care. Growing veterinary networks and e-commerce penetration make probiotics more accessible across second- and third-tier cities. Traditional medicine acceptance of microbiome-based therapies, particularly in China, creates cultural receptivity. International pet product companies are aggressively expanding distribution partnerships throughout the region, while local manufacturers develop region-specific formulations, collectively driving Asia Pacific's exceptional growth trajectory.

Key players in the market

Some of the key players in Pet Probiotics Market include ADM, Alltech, Inc., Kerry Group PLC, International Flavors & Fragrances Inc., dsm-firmenich, Cargill, Incorporated, Kemin Industries, Inc., Probi AB, BENEO GmbH, Ingredion Incorporated, Novonesis Group, Lallemand Inc., Chr. Hansen Holding A/S, Lesaffre Group, and Evonik Industries AG.

Key Developments:

In March 2026, ADM published a peer-reviewed clinical study in the journal Animals demonstrating that its PRIOME(R) Metabolic Health (PRIOME(R) MH), in both probiotic and heat-treated postbiotic forms, significantly supports metabolic health and blood glucose management in adult dogs.

In March 2026, Cargill, Incorporated completed a $3.5 billion investment at its Cedar Rapids, Iowa, facility to expand postbiotic fermentation capacity. This upgrade supports the Micronutrition & Health Solutions (MHS) portfolio, specifically targeting the global demand for science-based pet and livestock health solution.

In October 2025, Kemin Industries, Inc. launched VANNIX(TM) BP, a novel microbial-based probiotic blend aimed at supporting intestinal health in pets. The launch included new clinical data regarding its efficacy in reducing pathogenic bacteria in the canine digestive tract.

Product Types Covered:

  • Food-Based Probiotics
  • Supplements

Forms Covered:

  • Powder
  • Soft Chews
  • Capsules
  • Liquid
  • Paste

Pet Types Covered:

  • Dogs
  • Cats
  • Birds
  • Small Mammals
  • Reptiles & Exotic Pets

Functionalities Covered:

  • Digestive Health
  • Immunity Enhancement
  • Allergy & Skin Health
  • Oral & Dental Health
  • Weight Management
  • Overall Wellness

Ingredients Covered:

  • Lactobacillus
  • Bifidobacterium
  • Bacillus (Soil-Based Organisms)
  • Streptococcus
  • Yeast-Based Probiotics
  • Multi-Strain Blends

Claims Covered:

  • All-Natural
  • Non-GMO
  • Grain-Free
  • Organic
  • Allergen-Free
  • No Artificial Additives/Preservatives

End Users Covered:

  • Individual Pet Owners
  • Veterinary & Clinical Use
  • Pet Breeders & Shelters

Distribution Channels Covered:

  • Online
  • Offline

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Probiotics Market, By Product Type

  • 5.1 Food-Based Probiotics
    • 5.1.1 Dry Food
    • 5.1.2 Wet Food
    • 5.1.3 Treats & Functional Snacks
  • 5.2 Supplements
    • 5.2.1 Single-Strain Probiotics
    • 5.2.2 Multi-Strain Probiotics

6 Global Pet Probiotics Market, By Form

  • 6.1 Powder
  • 6.2 Soft Chews
  • 6.3 Capsules
  • 6.4 Liquid
  • 6.5 Paste

7 Global Pet Probiotics Market, By Pet Type

  • 7.1 Dogs
  • 7.2 Cats
  • 7.3 Birds
  • 7.4 Small Mammals
  • 7.5 Reptiles & Exotic Pets

8 Global Pet Probiotics Market, By Functionality

  • 8.1 Digestive Health
  • 8.2 Immunity Enhancement
  • 8.3 Allergy & Skin Health
  • 8.4 Oral & Dental Health
  • 8.5 Weight Management
  • 8.6 Overall Wellness

9 Global Pet Probiotics Market, By Ingredient

  • 9.1 Lactobacillus
  • 9.2 Bifidobacterium
  • 9.3 Bacillus (Soil-Based Organisms)
  • 9.4 Streptococcus
  • 9.5 Yeast-Based Probiotics
  • 9.6 Multi-Strain Blends

10 Global Pet Probiotics Market, By Claim

  • 10.1 All-Natural
  • 10.2 Non-GMO
  • 10.3 Grain-Free
  • 10.4 Organic
  • 10.5 Allergen-Free
  • 10.6 No Artificial Additives/Preservatives

11 Global Pet Probiotics Market, By End User

  • 11.1 Individual Pet Owners
  • 11.2 Veterinary & Clinical Use
  • 11.3 Pet Breeders & Shelters

12 Global Pet Probiotics Market, By Distribution Channel

  • 12.1 Online
    • 12.1.1 E-commerce Platforms
    • 12.1.2 Brand Websites
  • 12.2 Offline
    • 12.2.1 Veterinary Clinics
    • 12.2.2 Pet Specialty Stores
    • 12.2.3 Supermarkets/Hypermarkets
    • 12.2.4 Pharmacies

13 Global Pet Probiotics Market, By Geography

  • 13.1 North America
    • 13.1.1 United States
    • 13.1.2 Canada
    • 13.1.3 Mexico
  • 13.2 Europe
    • 13.2.1 United Kingdom
    • 13.2.2 Germany
    • 13.2.3 France
    • 13.2.4 Italy
    • 13.2.5 Spain
    • 13.2.6 Netherlands
    • 13.2.7 Belgium
    • 13.2.8 Sweden
    • 13.2.9 Switzerland
    • 13.2.10 Poland
    • 13.2.11 Rest of Europe
  • 13.3 Asia Pacific
    • 13.3.1 China
    • 13.3.2 Japan
    • 13.3.3 India
    • 13.3.4 South Korea
    • 13.3.5 Australia
    • 13.3.6 Indonesia
    • 13.3.7 Thailand
    • 13.3.8 Malaysia
    • 13.3.9 Singapore
    • 13.3.10 Vietnam
    • 13.3.11 Rest of Asia Pacific
  • 13.4 South America
    • 13.4.1 Brazil
    • 13.4.2 Argentina
    • 13.4.3 Colombia
    • 13.4.4 Chile
    • 13.4.5 Peru
    • 13.4.6 Rest of South America
  • 13.5 Rest of the World (RoW)
    • 13.5.1 Middle East
      • 13.5.1.1 Saudi Arabia
      • 13.5.1.2 United Arab Emirates
      • 13.5.1.3 Qatar
      • 13.5.1.4 Israel
      • 13.5.1.5 Rest of Middle East
    • 13.5.2 Africa
      • 13.5.2.1 South Africa
      • 13.5.2.2 Egypt
      • 13.5.2.3 Morocco
      • 13.5.2.4 Rest of Africa

14 Strategic Market Intelligence

  • 14.1 Industry Value Network and Supply Chain Assessment
  • 14.2 White-Space and Opportunity Mapping
  • 14.3 Product Evolution and Market Life Cycle Analysis
  • 14.4 Channel, Distributor, and Go-to-Market Assessment

15 Industry Developments and Strategic Initiatives

  • 15.1 Mergers and Acquisitions
  • 15.2 Partnerships, Alliances, and Joint Ventures
  • 15.3 New Product Launches and Certifications
  • 15.4 Capacity Expansion and Investments
  • 15.5 Other Strategic Initiatives

16 Company Profiles

  • 16.1 ADM
  • 16.2 Alltech, Inc.
  • 16.3 Kerry Group PLC
  • 16.4 International Flavors & Fragrances Inc.
  • 16.5 dsm-firmenich
  • 16.6 Cargill, Incorporated
  • 16.7 Kemin Industries, Inc.
  • 16.8 Probi AB
  • 16.9 BENEO GmbH
  • 16.10 Ingredion Incorporated
  • 16.11 Novonesis Group
  • 16.12 Lallemand Inc.
  • 16.13 Chr. Hansen Holding A/S
  • 16.14 Lesaffre Group
  • 16.15 Evonik Industries AG

List of Tables

  • Table 1 Global Pet Probiotics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pet Probiotics Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Pet Probiotics Market Outlook, By Food-Based Probiotics (2023-2034) ($MN)
  • Table 4 Global Pet Probiotics Market Outlook, By Dry Food (2023-2034) ($MN)
  • Table 5 Global Pet Probiotics Market Outlook, By Wet Food (2023-2034) ($MN)
  • Table 6 Global Pet Probiotics Market Outlook, By Treats & Functional Snacks (2023-2034) ($MN)
  • Table 7 Global Pet Probiotics Market Outlook, By Supplements (2023-2034) ($MN)
  • Table 8 Global Pet Probiotics Market Outlook, By Single-Strain Probiotics (2023-2034) ($MN)
  • Table 9 Global Pet Probiotics Market Outlook, By Multi-Strain Probiotics (2023-2034) ($MN)
  • Table 10 Global Pet Probiotics Market Outlook, By Form (2023-2034) ($MN)
  • Table 11 Global Pet Probiotics Market Outlook, By Powder (2023-2034) ($MN)
  • Table 12 Global Pet Probiotics Market Outlook, By Soft Chews (2023-2034) ($MN)
  • Table 13 Global Pet Probiotics Market Outlook, By Capsules (2023-2034) ($MN)
  • Table 14 Global Pet Probiotics Market Outlook, By Liquid (2023-2034) ($MN)
  • Table 15 Global Pet Probiotics Market Outlook, By Paste (2023-2034) ($MN)
  • Table 16 Global Pet Probiotics Market Outlook, By Pet Type (2023-2034) ($MN)
  • Table 17 Global Pet Probiotics Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 18 Global Pet Probiotics Market Outlook, By Cats (2023-2034) ($MN)
  • Table 19 Global Pet Probiotics Market Outlook, By Birds (2023-2034) ($MN)
  • Table 20 Global Pet Probiotics Market Outlook, By Small Mammals (2023-2034) ($MN)
  • Table 21 Global Pet Probiotics Market Outlook, By Reptiles & Exotic Pets (2023-2034) ($MN)
  • Table 22 Global Pet Probiotics Market Outlook, By Functionality (2023-2034) ($MN)
  • Table 23 Global Pet Probiotics Market Outlook, By Digestive Health (2023-2034) ($MN)
  • Table 24 Global Pet Probiotics Market Outlook, By Immunity Enhancement (2023-2034) ($MN)
  • Table 25 Global Pet Probiotics Market Outlook, By Allergy & Skin Health (2023-2034) ($MN)
  • Table 26 Global Pet Probiotics Market Outlook, By Oral & Dental Health (2023-2034) ($MN)
  • Table 27 Global Pet Probiotics Market Outlook, By Weight Management (2023-2034) ($MN)
  • Table 28 Global Pet Probiotics Market Outlook, By Overall Wellness (2023-2034) ($MN)
  • Table 29 Global Pet Probiotics Market Outlook, By Ingredient (2023-2034) ($MN)
  • Table 30 Global Pet Probiotics Market Outlook, By Lactobacillus (2023-2034) ($MN)
  • Table 31 Global Pet Probiotics Market Outlook, By Bifidobacterium (2023-2034) ($MN)
  • Table 32 Global Pet Probiotics Market Outlook, By Bacillus (Soil-Based Organisms) (2023-2034) ($MN)
  • Table 33 Global Pet Probiotics Market Outlook, By Streptococcus (2023-2034) ($MN)
  • Table 34 Global Pet Probiotics Market Outlook, By Yeast-Based Probiotics (2023-2034) ($MN)
  • Table 35 Global Pet Probiotics Market Outlook, By Multi-Strain Blends (2023-2034) ($MN)
  • Table 36 Global Pet Probiotics Market Outlook, By Claim (2023-2034) ($MN)
  • Table 37 Global Pet Probiotics Market Outlook, By All-Natural (2023-2034) ($MN)
  • Table 38 Global Pet Probiotics Market Outlook, By Non-GMO (2023-2034) ($MN)
  • Table 39 Global Pet Probiotics Market Outlook, By Grain-Free (2023-2034) ($MN)
  • Table 40 Global Pet Probiotics Market Outlook, By Organic (2023-2034) ($MN)
  • Table 41 Global Pet Probiotics Market Outlook, By Allergen-Free (2023-2034) ($MN)
  • Table 42 Global Pet Probiotics Market Outlook, By No Artificial Additives / Preservatives (2023-2034) ($MN)
  • Table 43 Global Pet Probiotics Market Outlook, By End User (2023-2034) ($MN)
  • Table 44 Global Pet Probiotics Market Outlook, By Individual Pet Owners (2023-2034) ($MN)
  • Table 45 Global Pet Probiotics Market Outlook, By Veterinary & Clinical Use (2023-2034) ($MN)
  • Table 46 Global Pet Probiotics Market Outlook, By Pet Breeders & Shelters (2023-2034) ($MN)
  • Table 47 Global Pet Probiotics Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 48 Global Pet Probiotics Market Outlook, By Online (2023-2034) ($MN)
  • Table 49 Global Pet Probiotics Market Outlook, By E-commerce Platforms (2023-2034) ($MN)
  • Table 50 Global Pet Probiotics Market Outlook, By Brand Websites (2023-2034) ($MN)
  • Table 51 Global Pet Probiotics Market Outlook, By Offline (2023-2034) ($MN)
  • Table 52 Global Pet Probiotics Market Outlook, By Veterinary Clinics (2023-2034) ($MN)
  • Table 53 Global Pet Probiotics Market Outlook, By Pet Specialty Stores (2023-2034) ($MN)
  • Table 54 Global Pet Probiotics Market Outlook, By Supermarkets / Hypermarkets (2023-2034) ($MN)
  • Table 55 Global Pet Probiotics Market Outlook, By Pharmacies (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.